Funding Acknowledgements: Curtin University Topic: Chronic Heart Failure -Other Background: Ventricular assist devices (VAD) are implanted to augment cardiac output in advanced chronic heart failure (CHF). VAD are associated with an increased survival, quality of life and aerobic capacity in patients with CHF. However, few studies have evaluated the effects of VAD on daily physical activity. Purpose: This study tested the hypothesis that participants with VAD engage in higher levels of physical activity compared with well-matched CHF participants. Methods: This was a prospective, case-controlled study. Sixteen participants with a VAD in situ (age: 59.1AE10.8 years, mean AE SD) were case-matched to sixteen advanced CHF participants (New York Heart Association Functional Class III/IV) (age: 58.3AE8.7 years) who were listed or being considered for cardiac transplantation. Participants underwent a cardiopulmonary exercise test to determine peak oxygen consumption (peak VO2). Physical activity was monitored continuously for seven consecutive days with an Actiheart accelerometer. Between group differences were compared with independent t-tests. Spearman correlation coefficient was applied to determine associations between variables. Statistical significance was set at p < 0.05. Results: Peak VO2 in the CHF group (12.3AE3.5 ml/kg/min) was not significantly different to the VAD group prior to implantation (10.2AE2.1 ml/kg/min), but was lower than that in the VAD group following implantation (15.4AE4.3ml/kg/min) (p< 0.05). Physical activity was higher in the VAD (1691AE707 kJ/day) compared with the CHF group (945AE680 kJ/day; p= 0.013). Participants with VAD spent more time performing moderate intensity physical activity (3-6 METs) than their CHF counterparts (31AE22 minutes/day vs 12AE17 minutes/day respectively; p= 0.012). Sedentary time was lower in VAD versus CHF participants (1275AE98 minutes/day vs 1339AE75 minutes/day; p< 0.048). Peak VO2 was positively correlated with physical activity when data was pooled for both groups (rs= 0.523, p= 0.003). Conclusion: Higher levels of physical activity were observed in participants with VAD compared with well-matched patients with advanced CHF, but no VAD. This may be due to a higher peak VO2 post VAD, resulting in an improved capacity to perform rehabilitative exercise and activities of daily living with less symptoms. These results highlight the effect of VAD implantation on improving functional capacity in people with advanced heart failure. Kitasato University School of Medicine, Department of Cardiovascular Medicine, Sagamihara, Japan Funding Acknowledgements: Topic: Chronic Heart Failure -Other Background: Chronic heart failure patients with preserved left ventricular ejection fraction (HFpEF) have exercise intolerance and poor prognosis as well as those with reduced ejection fraction (HFrEF). On the other hand, respiratory muscle weakness is frequently observed in HFrEF patients, which has been known as an independent predictor for lower survival rate. However, the relationship between respiratory muscle weakness and prognosis is still unknown in HFpEF patients. Purpose: We aimed to investigate whether respiratory muscle weakness predicted all-cause mortality in HFpEF patients. Methods: Consecutive 459 patients (67.9 AE 12.9 years, 190 females) were studied, who were hospitalized because of decompensated heart failure and whose left ventricular ejection fraction was ! 50%. We followed up them for three years and investigated their events on mortality. Patients who had received thoracic surgery in the last three months or had chronic respiratory diseases were excluded from this study. Clinical characteristics including body mass index, etiology of heart failure, medications, blood levels of hemoglobin, albumin and brain natriuretic peptide, estimated glomerular filtration rate and echocardiographic variables were obtained from clinical records. We also measured maximal inspiratory pressure (PImax) as respiratory muscle strength using a spirometer at hospital discharge. Patients were divided into three groups based on the tertile of PImax: low PImax (PImax 34.6 cmH2O), moderate PImax (34.6 <PImax 55.1 cmH2O) and high PImax (PImax > 55.1 cmH2O) groups. We compared survival rate between the three groups using Kaplan-Meier method with log-rank test. To identify the predictors for all-cause mortality, we performed multivariate Cox regression analysis and receiver operating characteristic (ROC) curve analysis using clinical characteristics and PImax as independent variables. Sensitivity versus specificity curve analysis was used to determine the cut-off value of predictors for all-cause mortality. Results: Forty-six patients (10.1%) died during the 3-year follow-up period. The mortality rate was 62.3/1,000 person-years. Three-year cumulative incidences of mortality were 16.3%, 8.5% and 5.2% in the low, moderate and high PImax groups, respectively. The low PImax group Abstract No: 356.
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showed significantly lower survival rate as compared with the other two groups (Figure 1 , logrank: 10.150, P = 0.001). Multivariate Cox regression analysis identified the PImax as an independent predictor for all-cause mortality (hazard ratio for PImax decrease of 10 cmH2O: 1.253, 95% CI: 1.078 -1.458, P = 0.003). Area under the ROC curve of PImax was 0.661 to predict all-cause mortality (95% CI: 0.582 0.740, P <0.001). The cut-off value of PImax for all-cause mortality was 39.1 cmH2O with sensitivity of 0.610 and specificity of 0.612 ( Figure  2 Regional Health Care Agency, Regione Emilia-Romagna, General Directorship for Public Health and Integration Policy, Bologna, Italy
Funding Acknowledgements: Topic: Secondary Prevention Background: Poor cardiorespiratory fitness (CRF) has often been associated with incidence and severity of hypertension (HTN). Cardiopulmonary exercise testing is the "gold standard" for CRF determination (i.e. VO2peak). However, because of physical, financial and time limitations, direct VO2peak determination is often not routinely assessed in clinical settings. A moderate 1-km treadmill-walking test (1k-TWT) has been demonstrated to be a valid and simple tool for CRF estimation in an outpatient setting. Aim: To examine the association between VO2peak estimated during a 1k-TWT and all-cause mortality in a cohort of patients with HTN and known cardiovascular disease (CVD). Methods: 711 patients aged 30 to 85 (mean 62 AE 10 years) underwent 1k-TWT, and were followed for all-cause mortality for up to 10 years. The 1k-TWT was individualized at a moderate perceptually-regulated exercise intensity (11-13 on the 6-20 Borg scale). Age, body mass index, heart rate, and time to complete the 1-km treadmill walk were entered into the equations originally validated for VO2peak estimation. Subjects were stratified into quartiles according to baseline VO2peak and mortality risks were calculated. Results: During a median follow-up of 9.6 years, survival decreased in a graded fashion from the highest VO2peak quartile to the lowest quartile. A total of 106 deaths from any cause occurred, and resulted 48 for the first (27% of the sample), 33 for the second (19% of the sample), 18 for the third (10% of the sample), and 7 for the fourth quartile (4% of the sample). Age, body mass index, left ventricular ejection fraction, smoking status, fasting glucose, total cholesterol, family history for CVD, history of previous coronary artery by-pass graft and acute myocardial infarction, and use of statins and diuretics were significantly associated with survival. Compared to the lowest quartile (average VO2peak 18.0 mL/kg/min, n = 178), the full-adjusted hazard ratios (95% confidence intervals) were 0.80 (0.41 to 1.57, P = 0.40) for the second quartile (average VO2peak 21.8 mL/kg/min, n = 178), 0.29 (0.11 to 0.77, P = 0.01) for the third quartile (average VO2peak 24.5 mL/kg/min, n = 177), and 0.05 (0.01 to 0.44, P = 0.007, n = 178) for the fourth quartile (average VO2peak 29.2 mL/kg/min, n = 178), P for trend <0.0001. Conclusions: Peak oxygen uptake estimated by a moderate and perceptually regulated 1k-TWT is a strong and independent predictor of all-cause mortality in patients with HTN and known CVD. Assessing VO2peak by the 1k-TWT can be a useful, simple and low cost tool to stratify and follow-up hypertensive patients with CVD through cardiac rehabilitation and secondary prevention programmes. Funding Acknowledgements: Topic: Diabetes and the Heart Purpose:Diabetes prevention should be a major goal for public health. People with PreDiabetes (Pre-D) are the appropriate target group for diabetes prevention. A meta-analysis of 70 prospective cohort studies (1) estimated the minimum rate of conversion from PRE-D to T2DM as 35.6/1000 person-years of follow-up. We examined the impact of a preventive health check-up and lifestyle coaching on the risk of progression from Pre-D to T2DM in the Prevention First cohort. Methods: The study sample consisted of n=3000 men (mean age: 45,8AE7,2y) and n=1631 women (mean age: 45,6AE5,5y) who participated at least twice in the Prevention First Checkup between 2002 and 2017. PRE-D was defined according to the ADA Definition (fasting glucose 100-125 mg/dl and/or HbA1c 5,7-6,4%). Newly manifested T2DM was defined as not having T2DM in the first check-up and fasting glucose !126 mg/dl and/or HbA1c !6,5% in the second check-up or taking diabetes medication. Patients with PRE-D received a one-hour motivational lifestyle coaching including an comprehensible explanation of the pathophysiology of insulin resistance and its relation to diet composition, carbohydrate and fat metabolism, exercise, and diabetes risk. All patients were provided with an individualized exercise prescription (endurance and resistance training) and received individual dietary counselling with the objective to follow the "5 Prevention First nutrition rules" (see Table 1 ). Results: Of the 4631 participants, 1132 men (37,7%) and 265 women (16,3%) fulfilled the criteria for PRE-D. During a mean follow-up of 4.8 years for men and 4.5 years for women, there were 29 cases of newly manifested to T2DM in men and 8 cases in women respectively. This translates into a conversion rate of 5.6/1000 person-years in men and 7.0/1000 person-years in women. Compared to the expected incidence of T2DM in patients with Pre-D of 35.6/1000 personyears, the relative risk reduction for T2DM was 84.1% in men and 80.4% in women. Conclusion: The very low conversion rate from Pre-D to T2DM supports the Prevention First concept of a Mediterranean-style low-carb diet combined with a tailored exercise prescription for diabetes prevention.
The "5 Prevention First Nutrition Rules" 1. Reduce carbohydrates by avoiding sugar-sweetened beverages, foods with added sugar, bread and all refined carbohydrates. The higher the degree of insulin resistance, the more important is carbohydrate restriction. 2. Reduce energy density of meals by a high intake of raw and cooked vegetables and a moderate intake of fruits. 3. Eat enough protein with each meal for good satiation and long-lasting satiety. 4. Choose healthy fats (olive oil, canola oil, nuts and nut oils, fatty fish). Eat full fat dairy products. Avoid trans-fatty acids in fast food, sweets and bakery products. 5. Build up and use your muscles (resistance and endurance training). Guidelines on atrial fibrillation (AF) recommend using the CHA2DS2-VASc clinical decision rule for estimating stroke risk and to subsequently guide decision-making on oral anticoagulant therapy. Nevertheless, underuse of anticoagulants exists, especially in primary care. Providing general practitioners (GPs) with an automated decision support based on CHA2DS2-VASc may improve anticoagulant use and eventually prevent more strokes. Aim: To study the impact of an automated decision support in general practice on stroke prevention in patients with AF. Design: A cluster randomized trial in general practice. Methods: A total of 38 practices were randomized. In the index practices, GPs were provided with an automatically generated CHA2DS2-VASc based anticoagulant treatment recommendation. The GPs in the reference practices provided care as usual. The primary outcome was the incidence of ischaemic stroke, TIA and/or thromboembolism (TE). Secondary outcomes were bleeding and the proportion of patients on guideline recommended anticoagulant treatment.
Results: In total, 1129 AF patients were included in the 19 index practices and 1226 AF patients in the 19 reference practices. The median age was 77 (interquartile range (IQR) 68 75) years, and 48% were male. The median CHA2DS2-VASc score was 3.0 (IQR 2.0 5.0). Underuse of anticoagulants as recommended for patients with CHA2DS2-VASc score !2 was 6.6%. After a median follow-up of 2.7 years (IQR 2.3 3.0), the incidence rate per 100 person-years of ischaemic stroke/TIA/TE was 1.96 in the index group and 1.42 in the reference group (hazard ratio (HR) 1.3, 95% C.I. 0.8 2.1). No difference was observed in the rate of bleeding (0.79 versus 0.82), or in the underuse (7.2% versus 8.2%) or overuse (8.0% versus 7.9%) of anticoagulation. Conclusions: In this study in patients with AF in general practice, underuse of anticoagulants was relatively low. Nevertheless, providing general practitioners with CHA2DS2-VASc based decision support did not result in a reduction in stroke incidence, nor did it affect bleeding risk or anticoagulant over-or underuse.
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Effect of depression on all-cause mortality in patients with congestive heart failure and implanted cardiac devices Funding Acknowledgements: Topic: Depression and Heart Disease Background: It is well known that depression is associated with high risk of cardiovascular mortality and morbidity. However the impact of depression on mortality in patients with implanted cardiac devices has not been fully evaluated.
The purpose was to assess the association between depression and all-cause mortality in patients with congestive heart failure (CHF) and implanted cardiac devices. The number of young patients with myocardial infarction (MI) is increasing but data regarding their occupational profile after the event are limited. Purpose: To evaluate the employment status after discharge for first MI in patients younger than 45 years and the influence of major adverse cardiac events (MACE) on the return to work rate in these patients. Methods: We analyzed data from 127 consecutive young patients admitted for acute myocardial infarction in two emergency hospitals between 2011-2013 and who were prospectively followed up to 4 years (mean 3AE1 years). Baseline characteristics were obtained from medical records while yearly interview of the patients, using a standardized questionnaire, assessed both occupational status (full/part time employment, professional reorientation, sick leave, disability retirement, unemployment) and MACE rate (composite of cardiovascular death, new myocardial infarction, further revascularization and emergency cardiovascular readmissions).
Results: The mean age of the patients was 39AE5 years with 91% of them being male. Two years after discharge, 98 patients (77%) had returned to work (full employment in 63%, 7% of patients were professionally reoriented and 7% had part time work), 3 patients (2%) were on sick leave, 17 patients (13%) had taken early retirement and 10 patients (8%) were unemployed. One third of the studied group (40 patients) experienced at least one MACE during the follow-up period. Unadjusted analysis showed that employment status is significantly impaired in the young patients that had MACE after AMI OR 7.09, [95% CI, 2.79-17.96], p <0.0001. Conclusions: One in 4 young patients fails to return to work after an AMI and the free-event survival associates with a higher rate of employment in these patients. Funding Acknowledgements: Topic: Secondary Prevention Introduction: Secondary prevention strategies are of utmost importance after a cardiovascular (CV) event or intervention. The active screening and treatment of known CV risk factors is broadly recommended by major scientific societies. The optimal strategy for SP in the elderly is widely discussed, as evidence is much less conclusive. Frailty, polypharmacy and multiple comorbidities are among the reasons that may lead to less intensive SP measures in octogenarians.
